These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 30245975)

  • 1. Urinary Markers in Bladder Cancer: An Update.
    Santoni G; Morelli MB; Amantini C; Battelli N
    Front Oncol; 2018; 8():362. PubMed ID: 30245975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers.
    Lopez-Beltran A; Cheng L; Gevaert T; Blanca A; Cimadamore A; Santoni M; Massari F; Scarpelli M; Raspollini MR; Montironi R
    Expert Rev Mol Diagn; 2020 Feb; 20(2):231-243. PubMed ID: 31795775
    [No Abstract]   [Full Text] [Related]  

  • 3. CYR61 as a potential biomarker for the preoperative identification of muscle-invasive bladder cancers.
    Chen H; Liu Y; Cao C; Xi H; Chen W; Zheng W; Dong X; Zheng S; Li L; Ma J; Gao Y; Shou J
    Ann Transl Med; 2021 May; 9(9):761. PubMed ID: 34268374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LC-MS metabolomics of urine reveals distinct profiles for non-muscle-invasive and muscle-invasive bladder cancer.
    Oto J; Fernández-Pardo Á; Roca M; Plana E; Cana F; Herranz R; Pérez-Ardavín J; Vera-Donoso CD; Martínez-Sarmiento M; Medina P
    World J Urol; 2022 Oct; 40(10):2387-2398. PubMed ID: 36057894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a Novel, Sensitive, and Specific Urine-Based Test for Recurrence Surveillance of Patients With Non-Muscle-Invasive Bladder Cancer in a Comprehensive Multicenter Study.
    Batista R; Vinagre J; Prazeres H; Sampaio C; Peralta P; Conceição P; Sismeiro A; Leão R; Gomes A; Furriel F; Oliveira C; Torres JN; Eufrásio P; Azinhais P; Almeida F; Gonzalez ER; Bidovanets B; Ecke T; Stinjs P; Pascual ÁS; Abdelmalek R; Villafruela A; Beardo-Villar P; Fidalgo N; Öztürk H; Gonzalez-Enguita C; Monzo J; Lopes T; Álvarez-Maestro M; Servan PP; De La Cruz SMP; Perez MPS; Máximo V; Soares P
    Front Genet; 2019; 10():1237. PubMed ID: 31921291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid biopsy: a step forward towards precision medicine in urologic malignancies.
    Di Meo A; Bartlett J; Cheng Y; Pasic MD; Yousef GM
    Mol Cancer; 2017 Apr; 16(1):80. PubMed ID: 28410618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can urinary biomarkers replace cystoscopy?
    Maas M; Bedke J; Stenzl A; Todenhöfer T
    World J Urol; 2019 Sep; 37(9):1741-1749. PubMed ID: 30283995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased accuracy of a novel mRNA-based urine test for bladder cancer surveillance.
    Pichler R; Fritz J; Tulchiner G; Klinglmair G; Soleiman A; Horninger W; Klocker H; Heidegger I
    BJU Int; 2018 Jan; 121(1):29-37. PubMed ID: 28941000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers in Bladder Cancer Surveillance.
    Sugeeta SS; Sharma A; Ng K; Nayak A; Vasdev N
    Front Surg; 2021; 8():735868. PubMed ID: 34651010
    [No Abstract]   [Full Text] [Related]  

  • 10. Follow-up in non-muscle-invasive bladder cancer-International Bladder Cancer Network recommendations.
    Kassouf W; Traboulsi SL; Schmitz-Dräger B; Palou J; Witjes JA; van Rhijn BW; Grossman HB; Kiemeney LA; Goebell PJ; Kamat AM
    Urol Oncol; 2016 Oct; 34(10):460-8. PubMed ID: 27368880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-based liquid biopsy: insights into early detection, prediction, and treatment monitoring of bladder cancer.
    Li S; Xin K; Pan S; Wang Y; Zheng J; Li Z; Liu X; Liu B; Xu Z; Chen X
    Cell Mol Biol Lett; 2023 Apr; 28(1):28. PubMed ID: 37016296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of non-invasive urinary biomarkers in bladder cancer.
    Lee HH; Kim SH
    Transl Cancer Res; 2020 Oct; 9(10):6554-6564. PubMed ID: 35117265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer.
    Roperch JP; Grandchamp B; Desgrandchamps F; Mongiat-Artus P; Ravery V; Ouzaid I; Roupret M; Phe V; Ciofu C; Tubach F; Cussenot O; Incitti R
    BMC Cancer; 2016 Sep; 16(1):704. PubMed ID: 27586786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective Validation of an mRNA-based Urine Test for Surveillance of Patients with Bladder Cancer.
    Valenberg FJPV; Hiar AM; Wallace E; Bridge JA; Mayne DJ; Beqaj S; Sexton WJ; Lotan Y; Weizer AZ; Jansz GK; Stenzl A; Danella JF; Shepard B; Cline KJ; Williams MB; Montgomery S; David RD; Harris R; Klein EW; Bradford TJ; Wolk FN; Westenfelder KR; Trainer AF; Richardson TA; Egerdie RB; Goldfarb B; Zadra JA; Ge S; Zhao S; Simon IM; Campbell SA; Rhees B; Bates MP; Higuchi RG; Witjes JA
    Eur Urol; 2019 May; 75(5):853-860. PubMed ID: 30553612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Liquid Biopsy in Bladder Cancer-The Current Landscape in Urinary Biomarkers.
    Matuszczak M; Kiljańczyk A; Salagierski M
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular markers in disease detection and follow-up of patients with non-muscle invasive bladder cancer.
    Maas M; Walz S; Stühler V; Aufderklamm S; Rausch S; Bedke J; Stenzl A; Todenhöfer T
    Expert Rev Mol Diagn; 2018 May; 18(5):443-455. PubMed ID: 29707982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A methylation assay for the detection of non-muscle-invasive bladder cancer (NMIBC) recurrences in voided urine.
    Zuiverloon TC; Beukers W; van der Keur KA; Munoz JR; Bangma CH; Lingsma HF; Eijkemans MJ; Schouten JP; Zwarthoff EC
    BJU Int; 2012 Mar; 109(6):941-8. PubMed ID: 21756281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Cell-Free DNA in Liquid Biopsies as Potential Biomarker for Bladder Cancer: A Systematic Review.
    Herranz R; Oto J; Plana E; Fernández-Pardo Á; Cana F; Martínez-Sarmiento M; Vera-Donoso CD; España F; Medina P
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33810039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine markers for detection and surveillance of non-muscle-invasive bladder cancer.
    Tilki D; Burger M; Dalbagni G; Grossman HB; Hakenberg OW; Palou J; Reich O; Rouprêt M; Shariat SF; Zlotta AR
    Eur Urol; 2011 Sep; 60(3):484-92. PubMed ID: 21684071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of the Bladder EpiCheck™ Methylation Test for Patients Under Surveillance for Non-muscle-invasive Bladder Cancer: Results of a Multicenter, Prospective, Blinded Clinical Trial.
    Witjes JA; Morote J; Cornel EB; Gakis G; van Valenberg FJP; Lozano F; Sternberg IA; Willemsen E; Hegemann ML; Paitan Y; Leibovitch I
    Eur Urol Oncol; 2018 Sep; 1(4):307-313. PubMed ID: 31100252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.